Defence Therapeutics Expands Radiopharmaceutical Development Strategy with Alpha and Beta-Emitter Programs

Go back to Defence Therapeutics Expands Radiopharmaceutical Development Strategy with Alpha and Beta-Emitter Programs
(AMEX: DTCFF) Delayed: 0.37 --0 (-0%)
Previous Close $0.37    52 Week High
Open $0.37    52 Week Low
Day High $0.37    P/E N/A 
Day Low $0.37    EPS
Volume 2,596